Loading...
J B Chemicals AND Pharmaceuticals Limited — Mebendazole Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Mebendazole · $539.7K export value · DGFT Verified
J B Chemicals AND Pharmaceuticals Limited is the #4 Indian exporter of Mebendazole with $539.7K in export value and 94 verified shipments. J B Chemicals AND Pharmaceuticals Limited holds a 3.9% market share in Mebendazole exports across 4 countries. The company exports 20 pharmaceutical products worth $47.9M across 12 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $479.0K | 105 | 56.1% |
| ETHIOPIA | $312.7K | 22 | 36.6% |
| MYANMAR | $19.3K | 3 | 2.3% |
| SUDAN | $19.0K | 1 | 2.2% |
| KENYA | $14.2K | 2 | 1.7% |
| THAILAND | $9.4K | 1 | 1.1% |
J B Chemicals AND Pharmaceuticals Limited exports Mebendazole to 6 countries. The largest destination is AUSTRALIA accounting for 56.1% of J B Chemicals AND Pharmaceuticals Limited's Mebendazole shipments, followed by ETHIOPIA (36.6%) and MYANMAR (2.3%). These destinations reflect J B Chemicals AND Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| INOVA PHARMACEUTICALS(AUSTRALIA) PT | AUSTRALIA | $119.0K | 24 |
| INOVA PHARMACEUTICALS (AUSTRALIA) P | AUSTRALIA | $116.6K | 26 |
| INOVA PHARMACEUTICALS AUSTRALIA P | AUSTRALIA | $100.4K | 16 |
| DEREJE ASNAKE WOLDEMICHAEL | ETHIOPIA | $89.7K | 6 |
| Y LIMITED 5 MILLNER AVENUE HORSLEY PARK | AUSTRALIA | $77.2K | 24 |
| INOVA PHARMACEUTICALS AUSTRALIA PT | AUSTRALIA | $65.8K |
India exported $7.1M worth of Mebendazole through 2,932 shipments from 259 suppliers to 108 countries, serving 756 buyers globally. J B Chemicals AND Pharmaceuticals Limited contributes $539.7K to this total, accounting for 3.9% of India's Mebendazole exports. J B Chemicals AND Pharmaceuticals Limited ships Mebendazole to 6 countries through 23 buyers.
J B Chemicals AND Pharmaceuticals Limited's average Mebendazole shipment value is $5.7K per consignment, based on 94 shipments totaling $539.7K. The largest destination is AUSTRALIA (56.1% of J B Chemicals AND Pharmaceuticals Limited's Mebendazole exports).
J B Chemicals AND Pharmaceuticals Limited ranks #4 among 259 Indian Mebendazole exporters with a 3.9% market share. The top 3 exporters are CADILA PHARMACEUTICALS LIMITED ($2.7M), LINCOLN PHARMACEUTICALS LTD ($1.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($539.7K). J B Chemicals AND Pharmaceuticals Limited processed 94 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VERMOREX (MEBENDAZOLE SUSP) 30ML ETH EXP | $164.1K | 13 |
| VERMOREX MEBENDAZOLE SUSP 30ML ETH EXP | $148.6K | 9 |
| MEBENDAZOLE TABLETS USP 100 MG.EACH TABL | $132.6K | 19 |
| MEBENDAZOLE TABLETS USP 100 MG. EACH TAB | $104.3K | 9 |
| MEBENDAZOLE TABLETS USP 100 MG.EACH TABLET CONTAINS 100 MG OF MEBENDAZOLE USP.VERMOX ORG 1X6 TABS AUS EXP - BLISTER | $27.6K | 1 |
| MEBENDAZOLE TABLETS USP 100 MG. EACH TABLET CONTAINS 100MG OF MEBENDAZOLE USP VERMOX CHOC 100MG CHEW 1X6TABS AUS EXP | $26.1K | 3 |
| MEBENDAZOLE TABLETS USP 100 MG.EACH TABLET CONTAINS 100 MG OF MEBENDAZOLE USP VERMOX ORG 1X2 TABS AUS EXP - BLISTER | $20.0K | 2 |
| MEBENDAZOLE SUSP 30 ML SUD EXP | $19.0K |
What J B Chemicals AND Pharmaceuticals Limited must comply with to export Mebendazole to its top destination countries
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | CADILA PHARMACEUTICALS LIMITED | $2.7M | 111 | 9 | $24.2K |
| 3 | LINCOLN PHARMACEUTICALS LTD | $1.1M | 22 | 1 | $50.0K |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED ★ | $539.7K | 94 | 4 | $5.7K |
| 5 | PRASHI PHARMA PRIVATE LIMITED | $398.2K | 32 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 17.5% |
| SAHAR AIR | 450 | 15.3% |
| NHAVA SHEVA SEA (INNSA1) | 300 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 289 | 9.9% |
| JNPT/ NHAVA SHEVA SEA | 170 | 5.8% |
| DELHI AIR | 162 | 5.5% |
| JNPT | 130 | 4.4% |
| AHEMDABAD ICD | 96 | 3.3% |
Visual overview of India's mebendazole supplier profile for J B Chemicals AND Pharmaceuticals Limited — top suppliers, destinations, pricing, and trade routes
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like JB Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the US East Coast, necessitating strategic adjustments in pricing and logistics.
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. JB Pharma can leverage this shift by emphasizing its compliance with stringent US regulatory standards and its capacity to meet large-scale demands.
The recent India–European Union Free Trade Agreement, concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU market. This development offers JB Pharma a competitive advantage, potentially increasing its export volumes to Europe and enhancing its market presence.
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. JB Pharma's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to regulated markets. The evolving regulatory environment, including the EU's Falsified Medicines Directive, requires continuous investment in serialization and traceability systems. JB Pharma's proactive approach to these requirements underscores its commitment to quality and patient safety.
J B Chemicals AND Pharmaceuticals Limited exports 20 products worth $47.9M. Beyond Mebendazole, top products include Cetirizine, Metronidazole, Ciprofloxacin, Enalapril, Caffeine. View the complete J B Chemicals AND Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Mebendazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for J B Chemicals AND Pharmaceuticals Limited's Mebendazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J B Chemicals AND Pharmaceuticals Limited
Full Company Profile →
20 products · $47.9M total trade · 12 categories
| 15 |
| MERCYMED TRADING PLC | ETHIOPIA | $50.7K | 4 |
| KARE PHARMACEUTICAL PLC | ETHIOPIA | $37.2K | 1 |
| SAMIEL BRHANE HABTU | ETHIOPIA | $29.6K | 2 |
| EMRAN AHMAD MOHAMMAD | ETHIOPIA | $19.5K | 1 |
J B Chemicals AND Pharmaceuticals Limited supplies Mebendazole to 23 buyers globally. The largest buyer is INOVA PHARMACEUTICALS(AUSTRALIA) PT (AUSTRALIA), followed by INOVA PHARMACEUTICALS (AUSTRALIA) P (AUSTRALIA) and INOVA PHARMACEUTICALS AUSTRALIA P (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| 1 |
| MEBENDAZOLE TABLETS USP 100 MG.EACH TABLET CONTAINS 100 MG OF MEBENDAZOLE USP VERMOX ORG 1X2 TABS AUS EXP - BLISTERNOS | $15.8K | 3 |
| MEBENDAZOLE TABLETS USP 100 MG. EACH TABLET CONTAINS 100MG OF MEBENDAZOLE USP VERMOX CHOC 100MG CHEW 1X6TABS AUS EXPNOS | $14.3K | 3 |
J B Chemicals AND Pharmaceuticals Limited exports 55 distinct Mebendazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VERMOREX (MEBENDAZOLE SUSP) 30ML ETH EXP with 13 shipments worth $164.1K.
| 3 |
| $12.4K |
| 6 | BEID HEALTHCARE PRIVATE LIMITED | $318.2K | 40 | 2 | $8.0K |
J B Chemicals AND Pharmaceuticals Limited ranks #4 among 259 Indian Mebendazole exporters. Average shipment value of $5.7K compared to the market average of $27.3K. The closest competitors by value are CADILA PHARMACEUTICALS LIMITED and LINCOLN PHARMACEUTICALS LTD.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 756+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for J B Chemicals AND Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mebendazole. For current shipment-level data, contact TransData Nexus.